Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The TETRIS trial

Eriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, Elisabetta Capomolla, Claudio Botti, Giuseppe Sanguineti, Paolo Marchetti, Elisabetta Anselmi, Silverio Tomao, Antonio Giordano, Corrado Ficorella, Katia Cannita, Lorenzo Livi, Icro Meattini, Maria Mauri, Filippo Greco, Enzo Maria Veltri, Andrea Michelotti, Luca Moscetti, Francesco GiottaVito Lorusso, Ida Paris, Federica Tomao, Daniele Santini, Giuseppe Tonini, Alice Villa, Vittorio Gebbia, Teresa Gamucci, Gennaro Ciliberto, Isabella Sperduti, Marco Mazzotta, Maddalena Barba, Patrizia Vici

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The TETRIS trial'. Together they form a unique fingerprint.

Medicine & Life Sciences